Keywords: autism, treatment, hope, lifts, repligen, acquired, rights

Autism treatment hope lifts Repligen

Article | 12 March 1999

Repligen has acquired the rights to develop the digestive hormonesecretin as a potential breakthrough treatment for autism after purchasing the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

SecreFlo

Secretin

Go to drug listing